首页> 外文期刊>Current medicinal chemistry >Intracellular location of KATP channels and sulphonylurea receptors in the pancreatic beta-cell: new targets for oral antidiabetic agents.
【24h】

Intracellular location of KATP channels and sulphonylurea receptors in the pancreatic beta-cell: new targets for oral antidiabetic agents.

机译:胰岛β细胞中KATP通道和磺酰脲受体在细胞内的位置:口服降糖药的新目标。

获取原文
获取原文并翻译 | 示例
           

摘要

Diabetes Mellitus is by far one of the most propagated chronic diseases, affecting 150 million people worldwide. This affliction is caused by a malfunction of pancreatic endocrine cells, which provokes a failure in the insulin release and glucose homeostasis. Plasma membrane K(ATP) channels have a key role in the stimulus-secretion coupling of pancreatic beta-cells. Consequently, many investigations have developed efficient drugs for the treatment of diabetes, such as sulphonylureas, which specifically close K(ATP) channels leading to an enhanced insulin secretion. Recent studies show that, in addition to its well-known plasma membrane location, sulphonylurea receptors and sulphonylurea-sensitive K(ATP) channels are also present in various intracellular sites including secretory granules, mitochondria, endoplasmic reticulum and more recently, the nucleus. What roles do they play in these organelles? Intracellular K(ATP) channels and sulphonylurea receptors, which operate in conjunction with classical pathways, can provide specific signaling circuits to establish direct links between extracellular signals and different cell functions, such as secretion or gene expression. The study of these intracellular channels provides novel perspectives in the signal transduction of the pancreatic beta-cell, and may offer clues for the development of new strategies in diabetes therapy. In this review we will address this topic with special emphasis on the biophysical basis and functional implications in the pancreatic beta-cell.
机译:糖尿病是迄今为止传播最广的慢性疾病之一,全世界有1.5亿人受到影响。这种痛苦是由胰腺内分泌细胞功能失调引起的,该功能失调引起了胰岛素释放和葡萄糖稳态的失败。质膜K(ATP)通道在胰腺β细胞的刺激分泌耦合中具有关键作用。因此,许多研究已经开发出用于治疗糖尿病的有效药物,例如磺酰脲类药物,该药物特异性地封闭了导致胰岛素分泌增强的K(ATP)通道。最近的研究表明,除了其众所周知的质膜位置外,磺酰脲受体和磺酰脲敏感的K(ATP)通道还存在于各种细胞内部位,包括分泌颗粒,线粒体,内质网以及最近的细胞核。它们在这些细胞器中扮演什么角色?与经典途径协同工作的细胞内K(ATP)通道和磺酰脲受体可以提供特定的信号传导电路,以在细胞外信号与不同细胞功能(例如分泌或基因表达)之间建立直接联系。这些细胞内通道的研究为胰腺β细胞的信号转导提供了新的视角,并可能为糖尿病治疗新策略的开发提供线索。在这篇综述中,我们将特别关注胰腺β细胞的生物物理基础和功能含义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号